SEC and FDA Announce MOU to Bolster Cooperation and Ensure Market
More in this Section Press Release SEC and FDA Announce MOU to Bolster Cooperation and Ensure Market Integrity For Immediate Release 2026-80 Washington D.…
Summary
More in this Section Press Release SEC and FDA Announce MOU to Bolster Cooperation and Ensure Market Integrity For Immediate Release 2026-80 Washington D. 31, 2026 — The Securities and Exchange Commission and the Food and Drug Administration today announced that they have entered into a Memorandum of Understanding (MOU) designed to assist the agencies in carrying out their respective missions of ensuring the integrity of the financial markets and protecting public health. The MOU establishes a framework for the agencies to enhance cooperation in their regulatory and enforcement responsibilities in order to improve market oversight and compliance. Among other things, the MOU includes information-sharing protocols to facilitate the exchange of information between the SEC and FDA that is relevant to both agencies’ important missions.
Positives
- More in this Section Press Release SEC and FDA Announce MOU to Bolster Cooperation and Ensure Market Integrity For Immediate Release 2026-80 Washington D.
- The MOU establishes a framework for the agencies to enhance cooperation in their regulatory and enforcement responsibilities in order to improve market oversight and compliance.
Risks & concerns
- The article may not provide enough evidence to validate every implication.
- Execution, cost, adoption, regulation, or security could change the outcome.
